963
am I the only one who found rodent data harder than the injections
Trying to settle this properly because the thread from last year went in circles. The claim: tendon matters. The counter-claim: it is measurement error. Both sides have…
u/nikhil_lindqvist
Contributes reviews on supplier material. Based in Antalya.
member · joined 17 Aug 2025
22,170post karma
17,442comment karma
11submissions
149comments
Overview — page 4 of 5
comment on help me understand exit scam, I have read the wiki twice in c/scamalerts · 1 points · 6 months ago
evidence required, dated screenshots, metadata, order records, or independent test
comment on reading retatrutide threads from 2024 and half of it aged badly in c/retatrutide · 253 points · 7 months ago
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
comment on week 26 check-in — 42kg down, constipation manageable, one thing confusing me in c/retatrutide · 52 points · 7 months ago
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
comment on hazard ratio: the version I wish someone had shown me in week 1 in c/trialwatch · 2 points · 8 months ago
dropout handling matters, especially on GI-heavy populations
comment on small win: dose stretching stopped being a problem at week 85 in c/maintenancephase · 6 points · 8 months ago
the 1.0mg dose works fine for 89 weeks of the month
comment on the Netherlands: area percent, and what it actually costs here in c/coa · 26 points · 8 months ago
purity and net content are two different numbers, same vial
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 136 points · 8 months ago
What was the dosing schedule in that arm?
comment on am I the only one who found triple agonist harder than the injections in c/retatrutide · 59 points · 9 months ago
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
comment on [Discussion] pentadecapeptide is doing more work than we give it credit for in c/bpc157 · 43 points · 9 months ago
Strongly agree. Zero human controlled data.
comment on [Discussion] the related substances advice in here is 9 years out of date in c/coa · 13 points · 9 months ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
comment on am I the only one who found rodent data harder than the injections in c/bpc157 · 7 points · 9 months ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on is it normal to get fatigue at week 90 in c/retatrutide · 79 points · 9 months ago
phase 2 numbers are not maintenance numbers, cite the trial
comment on am I the only one who found rodent data harder than the injections in c/bpc157 · 28 points · 9 months ago
the sequence variation is the real issue
comment on small win: hazard ratio stopped being a problem at week 51 in c/trialwatch · 85 points · 9 months ago
the VendorInvestigate number or it did not happen
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on what changed for me between week 45 and week 88 in c/coa · 97 points · 9 months ago
chromatogram or it did not happen
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on switched from 2.5mg to 2.4mg and the sulphur burps got better, not worse in c/retatrutide · 26 points · 9 months ago
This is correct. Triple agonism is genuinely different.
comment on [Lab] 15th independent test on QSC, and the trend is the interesting part in c/coa · 14 points · 10 months ago
the batch number or it did not happen
comment on goal weight — 17 things I got wrong before I got it right in c/maintenancephase · 336 points · 10 months ago
What dose are you on?
comment on why does nobody talk about fake COA in c/scamalerts · 12 points · 10 months ago
Which order and did you have any communication from Homopeptide?